Skip to main content Skip to section navigation Skip to footer
Aethlon Medical, Inc. Corporate Home
  • The Hemopurifier®
    • Overview
    • The Hemopurifier® in Cancer
    • The Hemopurifier® in Infectious Disease
  • About
    • Overview
    • Leadership
    • Board of Directors
  • News & Media
    • Press Releases
    • Presentations
    • Events
    • Publications
    • Training Videos
  • Investors
    • Overview
    • Corporate News / Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
    • Analyst Coverage
  • Contact Us
News & Media
  • Press Releases
  • Presentations
  • Events
  • Publications
  • Training Videos

Press Releases

Feb 1, 2016

Aethlon Medical to Present at the 18th Annual BIO CEO & Investor Conference

Jan 29, 2016

Aethlon Medical To Host Third Quarter Fiscal 2016 Investor Call on February 4, 2016

Jan 12, 2016

Aethlon Medical's Exosome Sciences To Participate In Clinical Research Study To Diagnose Chronic Traumatic Encephalopathy (CTE)

Nov 16, 2015

Aethlon Medical Announces Fiscal 2016 Second Quarter Results

Nov 10, 2015

Aethlon Medical to Participate in the IN3 Medical Device 360 Summit

Oct 26, 2015

Aethlon Medical To Host Second Quarter Fiscal 2016 Investor Call on November 16, 2015

Sep 28, 2015

Aethlon Medical Extends Contract with the Defense Advanced Research Projects Agency

Sep 2, 2015

Aethlon Medical to Present at the Rodman & Renshaw 17th Annual Global Investment Conference

Aug 13, 2015

Aethlon Medical Announces Fiscal 2016 First Quarter Results

Aug 6, 2015

Aethlon Medical (AEMD) CEO Note: Nasdaq listing, equity financing and therapeutic pipeline expansion

  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 17
  • Page 18
  • Page 19
  • Page 20
  • Page 21
  • Page 22
  • Page 23
  • Page 24
  • Page 25
  • Page 26
  • Next Pagearrow_forward
rss_feed News RSS
Linkedin
Privacy Policy Disclaimer Sitemap Accessibility Statement
©2025 Aethlon Medical, Inc. All Rights Reserved.